<?xml version="1.0" encoding="UTF-8"?>
<p>Follow-up appointments have been scheduled to allow early detection of possible adverse events and optimal evaluation of possible MSC-mediated effects through biomarkers, clinical change and objective change as detected with capillaroscopy and physical examination. Follow-up will be more frequent in the first 3 months, with the last follow-up visit 1 year after treatment to assess long-term safety.</p>
